Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.
Wills, K N
Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene. [electronic resource] - Cancer gene therapy Sep 1995 - 191-7 p. digital
Publication Type: Journal Article
0929-1903
Animals
Carcinoma, Hepatocellular--genetics
Cell Division--drug effects
Drug Resistance, Neoplasm--genetics
Ganciclovir--pharmacology
Genetic Therapy
Genetic Vectors--pharmacology
Herpesvirus 1, Human--genetics
Humans
Mice
Neoplasms, Experimental--drug therapy
Thymidine Kinase--genetics
alpha-Fetoproteins--biosynthesis
Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene. [electronic resource] - Cancer gene therapy Sep 1995 - 191-7 p. digital
Publication Type: Journal Article
0929-1903
Animals
Carcinoma, Hepatocellular--genetics
Cell Division--drug effects
Drug Resistance, Neoplasm--genetics
Ganciclovir--pharmacology
Genetic Therapy
Genetic Vectors--pharmacology
Herpesvirus 1, Human--genetics
Humans
Mice
Neoplasms, Experimental--drug therapy
Thymidine Kinase--genetics
alpha-Fetoproteins--biosynthesis